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Abstract To investigate the role of the cytochrome P-450 sys- 
tem in NO synthesis, cytochrome P-450IIIA, IIE and IA activi- 
ties were specifically inhibited by cimetidine (IIIA), clotrimazole 
(IIIA), benzoflavone (IA) and disulfiram (IIE) in a model of 
cultured rat hepatocytes. Cytokine-induced NO synthesis was 
significantly decreased in the presence of cimetidine and clotrima- 
zole. Kinetic analysis revealed a non-competitive mode of inhibi- 
tion (K i = 21 mM, cimetidine; K i = 13/xM, clotrimazole). Re- 
verse transcriptase-PCR and immunoblot analysis revealed no 
significant change in steady state levels of iNOS mRNA and 
protein expression with P-450IIIA inhibition. Purified iNOS en- 
zyme activity was not altered. These data suggest hat cytokine- 
mediated hepatocyte synthesis of NO is dependent upon P- 
450IIIA activity, which functions in a post-translational capacity. 
Key words: Nitric oxide; Cytochrome P-450; Cimetidine; 
Clotrimazole; Rat hepatocyte 
1. Introduction 
Nitric oxide (NO) is a short lived, readily diffusible free 
radical with a multitude of organ-specific functions [1]. The 
monoxygenase enzyme, NO synthase (NOS), catalyzes a five 
electron oxidation of  L-arginine with oxygen and NADPH as 
co-substrates to ultimately yield L-citrulline and NO via the 
intermediate, N-hydroxy-L-arginine (NOHA) [2,3]. Recently, 
using a system of rat liver microsomes devoid of NOS activity, 
Boucher and colleagues have described an alternative mecha- 
nism whereby cytochrome P-450-dependent monooxygenases 
catalyze the oxidation of NOHA to NO and citrulline [4,5]. To 
further characterize this observation, we examined the effect of 
specific inhibition of cytochrome P-450IIIA, I IE or IA activi- 
ties on NO synthesis in a model of rat hepatocytes in short term 
primary culture. Inhibition of CP-450IIIA activity by cimetid- 
ine or clotrimazole was associated with significantly decreased 
NO synthesis, while steady state levels of iNOS mRNA and 
protein expression did not change. In contrast, inhibition of 
P-450IIE or IA activity did not alter hepatocyte NO produc- 
tion. Addition of 7-ethoxyresorufin, a non-specific inhibitor of 
cytochrome P-450 activity, also decreased cytokine-mediated 
NO synthesis. Our results suggest hat (i) hepatocyte synthesis 
of NO is dependent upon cytochrome P-450 I I IA activity, (ii) 
P-450IIIA activity functions in a post-translational capacity, 
and (iii) imidazole-derived inhibitors of P-450IIIA activity 
modulate NOS activity by a non-competitive mode of inhibi- 
tion. 
*Corresponding author. Fax: (1) (415) 725-3918. 
2. Materials and methods 
2.1. Rat hepatocyte isolation 
Male Sprague-Dawley rats (200-300 g) were fed water and chow ad 
libitum. Hepatocyte isolation, as described by Schuetz and Guzelian, 
was performed using the technique of in situ collagenase perfusion 
followed by sequential Percoll gradient centrifugation [6]. Hepatocytes 
were resuspended in Williams' E media with 1 mM L-arginine, I/~M 
insulin, 15 mM HEPES, pH 7.4, penicillin, streptomycin, and 10% 
heat-inactivated low endotoxin ewborn bovine serum (NBS). Hepato- 
cyte purity was assessed by leukocyte sterase staining, while viability 
was assessed by Trypan blue exclusion. Preparations were routinely 
>90% viable and >98% pure. The cell suspension was incubated 
in plastic wells for 30 min to remove residual Kupffer cells. Hepatocytes 
were then plated at a density of 5.0 x 105 cells/ml onto gelatin-coated 
wells. After 2 h, the media were changed to remove unattached cells. 
After 24 h of incubation at 37°C in 95% 02/5% CO2, cells were washed 
twice and fresh media applied for experimental use. 
2.2. Preparation of microsomes from cultured rat hepatocytes 
Samples of isolated rat hepatocytes were homogenized in 4 vols. of 
250 mM sucrose, 0.1 M potassium phosphate, pH 7.4, 1 mM EDTA, 
0.1 mM dithiothreitol. After centrifugation at 10,000 × g for 25 min, the 
supernatant was again centrifuged at 100,000 x g for 1 h at 4°C. The 
pellet was homogenized in 0.1 M sodium pyrophosphate, pH 7.25, 23 
¢tM butylated hydroxytoluene, 1 mM EDTA and again, centrifuged at 
100,000 x g for 1 h at 4°C. The resulting microsomal preparation was 
suspended in 0.1 M potassium phosphate, pH 7.4, glycerol (20%, v/v), 
1 mM EDTA, 0.1 mM DTT. Microsomal preparations were kept at 
-70°C until ready for use [7]. 
2.3. Generation of NO in isolated rat hepatocytes 
Isolated rat hepatocytes were stimulated to produce NO by incuba- 
tion in Williams' E media with 10% heat inactivated NBS, and 1 mM 
L-arginine supplemented with 25 ng/ml IL-1,500 U/ml TNF, 100 U/ml 
h IFN, and 12 ¢tg/ml LPS (E. coli 0111 :B4) [8]. In selected instances, 
the competitive substrate inhibitor of NO synthase, Na-monomethyl-L- 
arginine (L-NMMA) was added to inhibit NO synthesis. Cimetidine 
(0-50 mM) or clotrimazole (0-50 ¢tM) were added as specific inhibitors 
of CP-450IIIA; similarly, disulfiram ((~I00 /tM) or benzoflavone 
(0-100/~M) were added as specific inhibitors of CP-450 liE and IA 
activities, respectively. After incubation for 18 h at 37°C in 95% 02/5% 
CO2, the supernatant was aspirated and the cells washed twice with 
DPBS. Following treatment with trypsin/EDTA, the hepatocytes were 
harvested for biochemical ssays. 
2.4. Measurement of NO 
NO release from cells in culture was quantified by measurement of 
the NO metabolite, nitrite, using the technique of Snell and Snell [9]. 
Conditioned media was mixed with 1% sulfanilamide in 0.5N HCI 
(50%; v/v). After a five minute incubation at room temperature, an 
equal volume of 0.02% naphthylenediamine was added. Following in- 
cubation at room temperature for 10 minutes, absorbance at 570 nm 
was compared with that of an NaNO2 standard. 
2.5. Determination of monooxygenase activities 
Cytochrome P-450 isoform-specific enzyme activities, ethoxyre- 
sorufin deethylase (IA), aniline hydroxylase (liE) and erythromicin 
demethylase (IliA), were assayed using previously published techniques 
[7,10,11]. Microsomes were diluted to 0.2 mg/ml in 0.1 M potassium 
phosphate, pH 7.4, and incubated at 37°C for 5 min in the presence of 
the appropriate substrate. The reaction was initiated by addition of 
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1 mM NADPH and allowed to proceed at 37°C. Final substrate con- 
centrations were 5/IM ethoxyresorufin, 1 mM erythromicin and 1 mM 
aniline. Turnover (pmol of product formed/mg/unit t me) was deter- 
mined from the initial part of the reaction where substrate oxidation 
was linear as a function of time. 
2.6. Immunoblot analysis of inducible NOS 
The hepatocytes were washed three times in phosphate buffered 
saline and incubated with boiling 2 x non-reducing electrophoresis 
sample buffer for 2 min. Separation was performed on a 12% SDS- 
PAGE, and then electrotransferred to apolyester-supported nitrocellu- 
lose membrane for 90 min at 150 mA. The membrane was blocked 
overnight at 4°C in TBS (10 mM Tris-HCI at pH 7.5, 150 mM NaC1) 
containing 3% BSA. Blocked membranes were incubated with im- 
munoblotting iNOS Ab, washed three times in TBS/0.1% Tween, and 
incubated with biotinylated sheep anti-murine IgG for 1 h. After wash- 
ing again three times, membranes were then incubated with strepav- 
idin-horseradish peroxidase conjugate. Following washing, bound Abs 
were detected by the ECL detection system (Amersham, Arlington 
Heights, IL). 
2. Z RNA extraction and reverse transcriptase-PCR 
Total cellular RNA was extracted by a commercial modification of 
the phenol/chloroform/isoamyl alcohol extraction method (Promega 
RNAgents Total RNA Isolation System; Promega Corp., Madison, 
WI) [12]. Upon completion of RNA extraction, all samples were treated 
with 10 U/jzl RNase-free DNase (Stratagene Cloning Systems, La Jolla, 
CA) for 10 min at 37°C, followed by inactivation at 100°C for 15 min. 
Cellular RNA (0.5/zg) was reverse transcribed by incubating samples 
for 45 rain at 42 ° C in 10/11 reverse transcriptase buffer containing 5
mM MgC12, 10 mM Tris, 0.25 mM dNTP, 0.5 U/ml RNase inhibitor, 
2.5 nM random hexamer, and 10 U/ktl Moloney murine leukemia virus 
reverse transcriptase (Gibco BRL, Gaithersburg, MD). The reaction 
was terminated by heating to 95°C for 5 min. The mRNA-PCR method 
was performed (20-30 cycles) by using a Perkin-Elmer GeneAmp PCR 
System 9600 with 10/.tl of the reverse transcription mix, 2.5 U/100 jzl 
Taq DNA polymerase (Gibco BRL, Gaithersburg, MD), and 0.5/zM 
oligonucleotide primer pairs (Operon Technologies Inc., Alameda, 
CA). The sequence of primer pairs for human vascular smooth muscle 
cell iNOS have been described [13] and are: TAGAGGAACATCTG- 
GCCAGG and TGGCCGACCTGATGTTGCCA. The sequence 
primer pairs for rat fl-actin mRNA, used to determine constitutive 
expression, have also been described [14] and are: CATCGTGGGC- 
CGCTCTAGGCAC and CCGGCCAGCCAAGTCCAGACGC. Am- 
plification was initiated by 1 min of denaturation at 94°C for 1 cycle 
followed by 20-30 cycles at 94°C for 30 s, 60°C for 30 s, and 72°C for 
2 min. After the last cycle of amplification, the samples were incubated 
for 10 rain at 72°C and then held at 4°C. Verification of the amplified 
PCR products was performed by automated DNA sequencing (Applied 
Biosystems, Foster City, CA) for both rat iNOS and rat fl-actin mRNA. 
The PCR products were visualized by UV illumination after electro- 
phoresis through 1.0% agarose (UltraPure, Sigma Chemical Co.) at 120 
V for 45 min and staining in Tris-borate-EDTA buffer (89 mM Tris, 
89 mM boric acid, and 2.5 mM EDTA, pH 8.2) containing 0.5/zg/ml 
ethidium bromide. DNA was visualized on a UV illuminator and gels 
were photographed with type 55 positive/negative film (Polaroid, Cam- 
bridge, MA). The negative films of the gel photographs were scanned 
with a computerized laser densitometer (Hoeffer Scientific Instruments, 
San Francisco,CA) and the area under the curve was normalized for 
fi-actin mRNA content. 
2.8. Purification of NOS 
Hepatocyte homogenates were prepared by washing the cells twice 
in PBS (pH 7.4); the cells were scraped off the culture wells and resus- 
pended in sonication buffer containing 20 mM Tris, pH 7.4, 0.5 mM 
EGTA, 0.5 mM EDTA, 1 mM DTT, 1 JIM leupeptin, 1/~M BH4 and 
0.2 mM phenylmethanesulfonyl fluoride. All manipulations were per- 
formed at 4°C. Cells were sonicated and centrifuged at 100,000 × g for 
15 min at 4°C. The 100,000 × g supernatant was applied to a 2',5'-ADP 
Sepharose column equilibrated with sonication buffer with 1 mM 
MgC12 and 100 mM NaC1. The column was washed with sonication 
buffer with 0.5 M NaCI, and NOS activity was eluted in sonication 
buffer supplemented with 5 mM NADPH and 10% glycerol (v/v). The 
eluate was concentrated (approximately 10-fold) by ultrafiltration 
through a cell with a 50 kDa cutoff membrane (Amicon). Enzyme, in 
the presence of 5/,tM BH4, was used immediately for determination f 
iNOS activity. 
2.9. Determination of iNOS activity 
NOS enzyme activity was determined by the conversion of [3H]L- 
arginine to t3H]L-eitrulline, as previously described [15]. The assay was 
performed in the presence and absence of cimetidine (50 mM) or clot- 
rimazole (50 HM). 
2.10. Determination of AST, LDH and protein 
AST and LDH in the cell culture supernatant were measured by 
chromogenic assay. Total protein was determined by the method of 
Lowry [16]. All measured values were normalized to total cell protein 
to correct for variation in cell number from well-to-well. Total cell 
protein varied by less than 10% among the various treatment groups. 
2.11. Statistical methods 
Data were analyzed with the two-way Student's t-test or analysis of 
variance (ANOVA) with Newman-Keuls post-hoc omparison, as ap- 
propriate. P values less than 0.05 were considered statistically signifi- 
cant. 
3. Results 
3.1. Effect of  P-450 isoform activity on cytokine-mediated 
hepatocyte synthesis of  NO 
Hepatocytes in primary culture were cytokine-stimulated to 
produce NO in the presence and absence of the P-450 isoform 
inhibitors: cimetidine (IIIA), clotrimazole (IIIA), benzoflavone 
(IA) and disulfiram (IIE). Unst imulated cells served as con- 
trols. In the setting ofcytokine stimulation, NO product ion was 
found to increase by 2-3 fold in comparison to controls. Addi- 
t ion of cimetidine (0-50 mM) or clotrimazole (G50/ IM)  did not 
alter steady state nitrite levels in control cells. In contrast, the 
presence of cimetidine or clotrimazole resulted in significantly 
decreased NO synthesis in stimulated cells (Fig. 1). For  both 
agents, kinetic analysis was consistent with a non-competit ive 
model of inhibition: K~ = 21 mM, Vmax i = 0.05 nm NO/mg pro- 
tein/min for cimetidine and Ki = 13/zM, Vm,x i = 0.08 nm NO/ 
mg protein/min for clotrimazole. In the presence of 7-ethoxyre- 
sorufin (0~50/zM), a non-specific inhibitor of P-450 reductase, 
cytokine-induced NO synthesis by hepatocytes was found to 
decrease in a significant fashion, while release of NO in control 
Table 1 
Microsomal cytochrome P-450 isoform activity in cultured rat hepato- 
cytes 
ED (IA) AH (IIE) ER (IIIA) 
Control 
Stimulated 
Stimulated +L-NMMA 
Control + cimetidine (50 mM) 
Stimulated +eimetidine (50 mM) 
Control + disulfiram (100 ,uM) 
Stimulated +disulfiram (100/zM) 
Control + benzoflavone (100/zM) 
Stimulated +benzoflavone (100/tM) 
3.2+0.6 407+35 89+10 
2.8+1.2 375+67 86+13 
3.7_+1.0 395+70 98+ 16 
2.5+0.8 389+59 10+8 ~ 
2.0+0.7 350+45 8+5"  
2.3+0.5 54+32 # 72+25 
2.6+0.7 43+27" 83_+17 
ND 394+37 87+_19 
ND 373+46 91+13 
# P < 0.01 vs. Control; *P < 0.01 vs. Stimulated. Data presented as 
mean + S.E.M. of three experiments performed in duplicate; ND, not 
detectable. P-450 isoform-specific a tivities of ethoxyresorufin deethy- 
lase (ED), aniline hydroxylase (AH) and erythromicin demethylase 
(ER) are expressed as pmol/mg/min. Cultured rat hepatocytes were 
incubated for 16 h at 37°C in the presence of IL-1, TNF, IFN and LPS 
to stimulate NO synthesis. L = NMMA (100 ~tM) was added as a 
specific substrate inhibitor of NO synthesis. Untreated hepatocytes 
served as controls. 
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Fig. 1. Nitric oxide production in control and cytokine-stimulated 
hepatocytes in the presence of the cytochrome P-450 IIIA inhibitors, 
cimetidine (0-50 mM) and clotrimazole (0-50/2M). Data are presented 
as mean + S.E.M. of four experiments. **P < 0.01 clotrimazole-stimu- 
lated vs. clotrimazole control; #P < 0.01 cimetidine-stimulated vs. ci- 
metidine control. ANOVA: P < 0.001 clotrimazole-stimulated; 
P < 0.001 cimetidine-stimulated. 
cells was unaltered (Fig. 2). In the presence of the P-450IA 
inhibitor, benzoflavone, or the P-450IIE inhibitor, disulfiram, 
NO synthesis was not significantly altered in either control or 
cytokine-stimulated h patocytes (Fig. 3). At these concentra- 
tions, the P-450 inhibitors were not intrinsically hepatotoxic, as 
demonstrated byAST and LDH measurements in the cell cul- 
ture supernatant (data not shown). These data indicate that 
cytokine-mediated hepatocyte synthesis of NO is decreased in 
the setting of either generalized inhibition of P-450 reductase 
function or specific inhibition of P-450IIIA activity. 
3.2. Cytochrome P-450 activity and cytokine-mediated NO
synthesis 
P-450 isoform-specific enzyme activity was measured to con- 
firm inhibition of P-450 activity (Table 1). Cytochrome P-450 
IA, liE and I l i a  activities were not significantly different in 
control and cytokine stimulated hepatocytes. NO production 
in stimulated cells was associated with marginally decreased 
P-450 isoform activity; however, this did not reach statistical 
significance. Similarly, cytokine stimulation i  the absence of 
NO synthesis, as represented by the 'Stimulated + L-NMMA' 
group, did not have significantly altered P-450 isoform activi- 
ties. In control and stimulated hepatocytes, cimetidine (50 mM) 
was associated with a 10-fold decrease in P-450IIIA activity 
(P < 0.01), while IA and l iE activity was not altered. In a 
similar fashion, disulfiram (100/JM) treatment resulted in a 6-8 
fold decrease in liE activity without significant alteration i  IA 
and I l i a  activities in either control or stimulated hepatocytes. 
Finally, benzoflavone (100/JM) was associated with non-de- 
tectable P-450IA activity in both control and stimulated hepa- 
tocytes. These results suggest that specific inhibition of 
P-450IA, liE and I l i a  activities occurred with benzoflavone, 
disulfiram and cimetidine, respectively. 
3.3. Effect of P-45OIllA inhibition on iNOS mRNA and protein 
expression 
eDNA from isolated rat hepatocytes was amplified using a 
single set of primers specific for iNOS and fl-actin. DNA se- 
quence analysis of the amplified PCR products revealed com- 
plete homology to rat iNOS and fl-actin. Amplification of 
eDNA isolated from hepatocytes incubated with cytokines ex- 
hibited an iNOS PCR product of the anticipated size (approx. 
250 bp) after 15 cycles. Further amplification showed a linear 
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Fig. 2. Nitric oxide production in control and cytokine-stimulated 
hepatocytes in the presence ofthe non-specific cytochrome P-450 reduc- 
tase inhibitor, 7-ethoxyresorufin (0-50 /JM). Data are presented as 
mean + S.E.M. of four experiments. **P < 0.01 control vs. stimulated 
hepatocytes. ANOVA: P < 0.001 cytokine-stimulated c lls. 
, ~ 7-ethoxyresorufin ~ ' ' r  T ~e 
t ~ 7-ethoxyresorufin 
stimulated i 
~-- ted 
2 0 5 j " ' ' ' i ' | I | i . . . .  i ' " " " 
I 0 25 50 75 100 125 
DISULF IRAM (~tM) 
and 
BENZOFLAVONE (pM) 
Fig. 3. Nitric oxide production in control and cytokine-stimulated 
hepatocytes in the presence of the cytochrome P-450 IA inhibitor, 
benzoflavone (0-100/JM) and the IIE inhibitor, disulfiram (0-100/JM). 
Data are presented as mean + S.E.M. of four experiments. 
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Fig. 4. Effect of cimetidine on steady state hepatocyte iNOS mRNA 
expression. (A) PCR analysis of inducible NOS (upper gel) and,8-actin 
(lower gel) mRNA in isolated rat hepatocytes, cDNA prepared by 
reverse transcription of500 ng RNA was amplified by PCR, and prod- 
ucts electrophoresed on a 1% agarose gel and stained with ethidium 
bromide. Lane 1, DNA 100 bp molecular weight marker; lanes 2,4, 
control hepatocyte in the absence and presence ofcimetidine (50 mM), 
respectively; anes 3,5, cytokine-stimulated c lls in the absence and 
presence ofcimetidine (50 mM). In the iNOS gel only: lane 6, control 
PCR reaction (no DNAse); lane 7, control PCR reaction (no reverse 
transcriptase); lane 8, control PCR reaction (no template). Gels are 
representative of three seperate experiments. (B)Densitometric analysis 
of iNOS mRNA PCR products normalized tofl-actin mRNA. Data are 
presented as mean + S.E.M. of three seperate experiments. 
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increase in PCR product between 15 and 25 cycles without 
further increase in PCR product beyond 25 cycles of amplifica- 
tion. Therefore, 23 amplification cycles were used in subsequent 
studies; negative controls included specimens without reverse 
transcriptase, DNase or template. 
RT-PCR of rat hepatocytes was performed in the presence 
and absence of 50 mM cimetidine (Fig. 4). Control hepatocytes 
did not exhibit iNOS mRNA expression (lane 2) and this find- 
ing was not altered by the presence of cimetidine (lane 4). iNOS 
mRNA was noted in cytokine-stimulated c lls in both the ab- 
sence and presence of the P-450IIIA inhibitor (lanes 3, 5). 
When iNOS mRNA expression was normalized to the ,8-actin 
mRNA standard, cytokine-stimulated h patocytes were found 
to express tatistically equivalent levels of iNOS mRNA. These 
results suggest hat inhibition of P-450IIIA isoform activity 
does not alter steady state iNOS mRNA expression in this 
model of isolated rat hepatocytes in primary culture. 
To determine the effect of P-450IIIA activity inhibition on 
iNOS protein levels, immunoblot analysis was performed (Fig. 
5). No iNOS protein was detected in control hepatocytes in the 
presence or absence of 50 mM cimetidine (lanes 1, 3). In the 
setting of cytokine stimulation, immunoblot s aining for hepa- 
tocyte iNOS was noted in the absence and presence of cimetid- 
ine (lanes 2, 4). The addition of the alternative P-450IIIA inhib- 
itor, clotrimazole (50/.tM), did not significantly alter iNOS 
protein content in stimulated cells (lane 5) and was not statisti- 
cally different from that found in the presence of cimetidine. 
These results indicate that the decrease in cytokine-induced NO
synthesis mediated by P-450IIIA inhibition is not the result of 
decreased iNOS protein mass. 
3.4. Effect of  P-450IIIA inhibition on iNOS enzyme activity 
iNOS was isolated and partially purified from cytokine-stim- 
ulated hepatocytes (Table 2). In the presence of the P-450IIIA 
inhibitors, cimetidine (50 raM) or clotrimazole (50/zM), there 
was no detectable difference in activity in comparison to that 
in the absence of the P-450IIIA inhibitors. This suggests that 
the decreased NO production oted in the presence of cimetid- 
ine and clotrimazole is not the result of direct inhibition of 
iNOS enzyme activity. 
4. Discuss ion 
Nitric oxide is generated by the monooxygenase, nitric oxide 
synthase, which is homologous to cytochrome P-450 reductase 
[1]. Like P-450, NOS contains iron-protoporphyrin IX with 
cysteine as the axial ferric ion. In the presence of NADPH and 
oxygen, L-arginine is oxidized to L-citrulline and NO [2,3]. The 
exact molecular pathway is yet to be fully clarified, but 
N-Hydroxy-L-arginine has been determined tobe an interme- 
diate in NO synthesis. Work by Boucher and colleagues has 
Table 2 
Effect of cimetidine and clotrimazole on 2',5'-ADP Sepharose purified 
iNOS enzyme activity 
Specific activity (ng/mg/min) 
iNOS 180 
iNOS + cimetidine (50 mM) 167 
iNOS + clotrimazole (50 mM) 199 
ND, none detected. Activity was measured induplicate by the citrulline 
assay. Data are representative of three preparations. 
14 PC. Kuo, K.Y. Abe/FEBS Letters 360 (1995) 10 14 
A 
1 2 3 4 5 6 
10 
Q 
E o 
U) 
C 
G) 
B 
7.5. 
2.5. 
T 
@iiii! 
- . - . - . - . - . - . - . - . -  - . -  
iiiilililililililiiii~ 
. . . . . . . . . .  
iiiililililililililili 
1 ........... iiiiiiiiiiiiiiiiiiiii! 
!@!iii!i! i@i!!iiii! 
ii!i!i@iii! i i i i i!@ 
• . - . . . . . - . . . . . . . - . - . - ,  . . . . . . . . . .  
2 3 4 
Lane  Numbers  
Fig. 5. Effect of cimetidine and clotrimazole on steady state hepatocyte 
iNOS protein levels. (A) Immunoblot of inducible iNOS protein in 
isolated rat hepatocytes. Protein extracts were electrophoresed on a 
12% polyacrylamide g l, electrotransferred to a nitrocellulae membrane 
and incubated with a murine monoclonal ntibody to iNOS. Visualiza- 
tion was performed with biotinylated sheep anti-murine IgG secondary 
antibody and strepavidin horseradish peroxidase conjugate. Bound an- 
tibodies were detected by the ECL detection system (Amersham, Ar- 
lington Heights, IL). Lanes 1,3, control cells in the absence and pres- 
ence of cimetidine (50 mM), respectively; lanes 2,4, cytokine-stimulated 
cells in the absence and presence of cimetidine (50 mM), respectively; 
lane 5, cytokine-stimulated cells in the presence of clotrimazole 
(50 pM); lane 6, positive control, murine macrophage iNOS. The gel 
is representative of three seperate xperiments. (B) Densitometric anal- 
ysis of iNOS immunoblots. Data are presented as mean + S.E.M. of 
three seperate xperiments. 
demonstrated that cytochrome P-450s may be involved in the 
final oxidation of NOHA to produce NO [4,5]. Also, in a rat 
liver microsome system devoid of NOS activity, specific induc- 
tion of P-450IIIA by dexamethasone is associated with signifi- 
cantly increased NOHA conversion to NO [4,17]. However, the 
applicability of this observation to the physiology of the intact 
hepatocyte is unknown. 
In this study, specific inhibition of P-450IIIA activity by 
cimetidine and clotrimazole was associated with decreased cy- 
tokine-mediated NO synthesis in a system of rat hepatocytes 
in primary culture. In addition, these imidazole-derivatives 
were found to behave as non-competitive inhibitors of NO 
synthesis. In contrast, inhibitors of P-450IIE and IA activities 
did not alter NO production. This would suggest that cytokine- 
mediated hepatocyte NO synthesis is dependent upon P- 
450IIIA activity. However, because NOS and P-450s both con- 
tain heme components and cimetidine and clotrimazole are 
both imidazole-derivatives which act by coordinating with a 
heme moiety, the possibility exists that NO synthesis is de- 
creased as the result of inhibition of NOS rather than P-450 
[18]. 7-Ethoxyresorufin is a cytochrome P-450 substrate which 
acts as a non-specific inhibitor of P-450 function [19]. In the 
presence of 7-ethoxyresorufin, NO synthesis was noted to be 
significantly reduced. In addition, measurement of purified 
iNOS enzyme activity was not altered by incubation with ci- 
metidine or clotrimazole. This serves as evidence that non- 
specific inhibition of cytochrome P-450 activity results in di- 
minished NO production and that cimetidine and clotrimazole 
act to decrease hepatocyte NO synthesis by specific inactivation 
of P-450IIIA rather than NOS. 
The effect of P-450IIIA inhibition on steady state iNOS 
mRNA and protein levels was characterized by RT-PCR and 
immunoblot analysis. Expression of iNOS mRNA and protein 
was not altered in the presence of these P-450 inhibitors. This 
would suggest that P-450IIIA activity plays a post-translational 
role in the synthesis of NO by hepatocyte iNOS. 
The role of the cytochrome P-450 system in NO synthesis by 
the intact hepatocyte has not been previously addressed. In a 
model of rat hepatocytes in primary culture, specific inhibition 
of P-450IIIA but not IIE or IA activity was associated with 
significant diminution of cytokine-induced NO production. 
These observations extend Boucher's findings regarding the 
stimulatory effect of P-450IIIA induction on hepatocyte micro- 
somal NO production [4,17]. The physiological significance of 
these observations in the whole organism remain unknown. 
However, given the emerging evidence concerning the protec- 
tive effect of hepatocyte NO synthesis in oxidative injury, strat- 
egies to induce or augment cytochrome P-450IIIA activity 
would be of potential utility [20]. 
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